06/30/2026 14:08
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an In...

Rio Grande Resources Announces Equity Grants

VANCOUVER, BC /ACCESS Newswire/ July 9, 2026 /Rio Grande Resources Ltd. (CSE:RGR)(OTCQB:RGRLF) ("Rio Grande" or "RIO" the "Company"), is pleased to announce that it has granted a total of 775,750 stock options (the "Options") and 776,795 restricted share units (the "RSUs"), collectively, (the "Awards"), to certain directors, officers, employees and consultants of the Company pursuant to the Company's Long-Term Incentive Plan. The grants were approved by the Board of Directors on July 8, 2026. The Awards are intended to align the...

VANCOUVER, BC /ACCESS Newswire/ July 9, 2026 /Rio Grande Resources Ltd. (CSE:RGR)(OTCQB:RGRLF) ("Rio Grande" or "RIO" the "Company"), is pleased to announce that it has granted a total of 775,750 stock options (the "Options") and 776,795 restricted share units (the "RSUs"), collectively, (the "Awards"), to certain directors, officers, employees and consultants of the Company pursuant to the Company's Long-Term Incentive Plan. The grants were approved by the Board of Directors on July 8, 2026. The Awards are intended to align the...
Anglais
07/07/2026 22:22
Empire State Building Observation Deck Run-Up Returns for 48th Annual Race on Oct. 6

The Empire State Building Observation Deck (ESB), atop the “World’s Most Famous Building,” today announced that general lottery registration is open for this year's Empire State Building Observation Deck Run-Up (ESBRU), which will run through July 20, 2026. The annual race, presented by NYU Langone Health and powered by Merrell, will take place on Oct. 6, 2026, at 8 p.m. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707902561/en...

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution

Caidyatoday announced a strategic combination withSimbec-Oriondesigned to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs...

Caidyatoday announced a strategic combination withSimbec-Oriondesigned to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs...
Anglais

Sauce Labs Becomes the First Dedicated Software Quality Platform to Achieve ISO 42001 Certification for Responsible AI

As AI takes on decisions that used to belong to engineers, the world's largest continuous testing cloud joins the small group of companies in any industry...

As AI takes on decisions that used to belong to engineers, the world's largest continuous testing cloud joins the small group of companies in any industry...
Anglais
06/30/2026 15:00
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With establis...